Skip to content

Clinical study of Fecal microbiota transplantation for treatment of autism

Clinical study of Fecal microbiota transplantation for treatment of autism

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014745
Enrollment
Unknown
Registered
2018-02-02
Start date
2018-02-05
Completion date
Unknown
Last updated
2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorders(ASD)

Interventions

Oral capsule group:FMT
Enema group:FMT

Sponsors

Department of Gastroenterology, Institute of Surgery Research, Daping hospital, Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 18 Years

Inclusion criteria

Inclusion criteria: (1) Children aged from 3 to 18 years old; (2) Definitive diagnosis of autism; (3) The custodian of children can fully understand and accept the informed consent of the study and voluntarily participate in; (4) To be able to undergo follow-up examination; (5) Accompanying with symptoms of gastrointestinal tract (such as constipation, diarrhea, etc.); (6) No probiotics have been taken in the last month.

Exclusion criteria

Exclusion criteria: (1) The administration of probiotics and antibiotics; (2) Antibiotics were used in last 7 days before entry of the study; (3) Fever; (4) Relying on tube feeding; (5) Accompanying with gastrointestinal disease (such as life - threatening intestinal obstruction, intestinal perforation, intestinal bleeding, ulcerative colitis, Crohn disease, celiac disease, or eosinophilia esophagitis) requiring immediate treatment; (6) Combined diagnosis of severe malnutrition or excessive weight loss or severe immunodeficiency disease; (7) History of severe allergies; (8) Monogenic disease; (9) Accompanying with mental disorder or depression; (10) patients who were unable to cooperate to complete the study; (11) the researchers think that the paitent is not suitable for the study.

Design outcomes

Primary

MeasureTime frame
Intestinal Permeability Analysis;Methane hydrogen exhalation test;16S ribosomal RNA approach for feces;

Countries

China

Contacts

Public ContactLi Ning

Department of Gastroenterology, Institute of Surgery Research, Daping hospital, Third Military Medical University

lnn161224@126.com+86 15902380020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026